我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
6
0 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
已完成
100.0%
暂无批准数据
- A 60-question survey of 800 patients with advanced or metastatic colorectal cancer across five countries revealed that treatment tolerability, quality of life impacts, and concerns about being a family burden are the top three factors driving treatment choices. - Patients rely heavily on oncology teams but also depend significantly on friends, family, and support networks including social media and peer support groups for treatment guidance. - Most survey respondents were unfamiliar with patient organization groups available in their countries, highlighting a gap that could be addressed by better connecting patients with these support resources. - The findings emphasize the need for a holistic approach addressing psychosocial and financial needs in advanced colorectal cancer care, with shared decision-making incorporating patient values beyond clinical parameters.